Leora Horn, MD, on Managing the Adverse Events of Combination Therapies

Posted: Monday, April 15, 2019

Leora Horn, MD, of Vanderbilt University, discusses the challenges of combining tyrosine kinase inhibitors with immunotherapy for lung cancer.